Efficacy of Comprehensive Diabetes Care (CDC) Management Program in Elderly Male Patients of Type II Diabetes Mellitus: A Retrospective Study
International Journal of Diabetes and Endocrinology
Volume 3, Issue 2, June 2018, Pages: 29-34
Received: Aug. 3, 2018;
Accepted: Sep. 7, 2018;
Published: Oct. 10, 2018
Views 937 Downloads 101
Rohit Sane, Department of Research and Development, Madhavbaug Cardiac Care Clinics and Hospitals, Mumbai, India
Pravin Ghadigaonkar, Department of Medical Operations, Madhavbaug Cardiac Care Clinics and Hospitals, Mumbai, India
Rekha Chaure, Madhavbaug Cardiac Care Clinics, Mumbai, India
Sangeeta Jain, Madhavbaug Cardiac Care Clinics, Mumbai, India
Shweta Wahane, Madhavbaug Cardiac Care Clinics, Nagpur, India
Aarti Nadapude, Madhavbaug Cardiac Care Clinics, Latur, India
Aarati Badre, Madhavbaug Cardiac Care Clinics, Mumbai, India
Rahul Mandole, Department of Research and Development, Madhavbaug Cardiac Care Clinics and Hospitals, Mumbai, India
Follow on us
Globally, Diabetes mellitus (DM) prevalence has created menace, being a major culprit of increased mortality and morbidity and health care expenditures. India is the 2nd country with maximum number of diabetic patients, with an estimated prevalence of around 10%. Comprehensive Diabetes Care (CDC) is a combination of Panchakarma and Diet management. This study was conducted to evaluate the effect of CDC on glycosylated haemoglobin (HbA1c), body mass index (BMI), body weight, abdominal girth and dependency on conventional therapy in DM Patients. This retrospective study was conducted from July 2017 to January 2018, wherein the data of elderly male type 2 DM patients (HbA1c >6.5%) who attended Madhavbaug clinics in Maharashtra, India were identified. Data of patients who were administered CDC (60-75 minutes) with minimum 6 sittings over 90 days (± 15 days) were considered. Variables were compared between day 1 and day 90 of CDC. Out of 48 enrolled elderly male patients, 34 were included for analysis. CDC showed significant improvement in HbA1c from 8.27 ± 0.96to 7.1 ± 1.30; p=0.0001), BMI from 27.65 ± 3.20 to 25.91 ± 3.29, p< 0.0001), weight from 73.75 ± 10.76to 69.46 ± 10.39, p<0.0001). Abdominal girth (from 100.0 ± 9.08 to 95.36 ± 9.10; p<0.0001), also showed significant reduction. Dependency on concomitant medicines was reduced, with number of patients on no concomitant medicines increasing from 3% to 15%. CDC and allopathy both are found to be efficacious; but CDC acts dually, by reducing HbA1c, as well as reducing dependency on allopathic medications.
Comprehensive Diabetes Care, CDC, Panchakarma, HbA1C, BMI, DM, Alternative Medicine
To cite this article
Efficacy of Comprehensive Diabetes Care (CDC) Management Program in Elderly Male Patients of Type II Diabetes Mellitus: A Retrospective Study, International Journal of Diabetes and Endocrinology.
Vol. 3, No. 2,
2018, pp. 29-34.
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Unwin N, Whiting D, Guariguata L, Ghyoot G, Gan D (Eds). The IDF Diabetes Atlas, 5th edition. Brussels, Belgium: International Diabetes Federation; 2011. pp. 7-12.
Vijayakumar G, Arun R, Kutty V. High Prevalence of Type 2 Diabetes Mellitus and Other Metabolic Disorders in Rural Central Kerala. JAPI. 2009; 57:563-7.
Singh PS, Sharma H, Zafar K, et al. Prevalence of type 2 diabetes mellitus in rural population of India- a study from Western Uttar Pradesh. Int J Res Med Sci 2017; 5:1363-7.
Verma M, Paneri S, Badi P, et al. Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity. Indian Journal of Clinical Biochemistry, 2006, 21 (1): 142-146.
Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. AMJ 2014, 7, 1, 45-48.
Ramachandran A. Type 2 diabetes in India: Challenges and possible solutions. Retrieved from http://www.apiindia.org/medicine_update_2013/chap40.pdf. [last accessed on 3rd June 2018].
Tripathi K, Srivastava A. Diabetes mellitus: Complications and therapeutics. Med Sci Monit, 2006; 12 (7): RA130-147.
Silva E, Ferriera C, Pinho L. Risk factors and complications in type 2 diabetes outpatients. Rev Assoc Med Bras 2017; 63 (7):621-627.
Complications of diabetes mellitus. Retrieved from http://semmelweis.hu/belgyogyaszat3/files/2017/05/Complications-of-diabetes-mellitus.pdf [last accessed on April 21st, 2018].
Matthaei S, Bierwirth R, Fritsche A, et al. Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2009; 117: 522 – 557.
Meneses M, Silva B, Sousa M, et al. Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism. Current Pharmaceutical Design. 2015; 21 (25): 3606-3620.
Egede L, Axon R, Gebregziabher M, et al. Medication Nonadherence in Diabetes. Diabetes Care. 2012; 35:2533–2539.
Elder C, Aickin M, Bauer V et al. Randomized Trial of a Whole-System Ayurvedic Protocol for Type 2 Diabetes. Alternative Therapies in Health and Medicine. 2006; 12 (5): 24-30.
Vidyashree K, Prasad K, Shilpa A. Role of Panchkarma in madhumeha w.s.r. to type 2 diabetes mellitus: a review. International Ayurvedic Journal. 2018; 6 (4): 835-840.
Choudhary U, Pandey A. A clinical assessment of the role of panchakarma therapy in the care of young prediabetics. International Journal of General Medicine and Pharmacy. 2013; 2 (1): 15-24.
Giri S, Patnaik S, Kumar K, et al. Potential of ayurvedic panchakarma in prevention and management of lifestyle disorders with special reference to madhumeha, J of Ayurveda and Hol Med (JAHM). 2015; 3 (5):82-91.
Nair D. Understanding the Role of Ayurveda Panchakarma Therapy W. S. R. to Vasthi (Enema) in the Management of Type II Diabetes Mellitus- A Case Review. Int J Complement Alt Med. 2017; 8 (6): 00276.
Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Retrived from http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf [Last accessed on Dec 21st 2017].
Uebaba K, Xu F, Ogawa H, et al. Psychoneuroimmunologic effects of ayurvedic oil dripping treatment. J Altern Complement Med. 2008; 14:1189–1198.
Sane R, Aklujkar A, Patil A, Mandole R. Effect of heart failure reversal treatment as add-on therapy in patients with chronic heart failure: A randomized, open-label study. Indian Heart Journal. 2017; 69 (3): 299-304.
“Clinical importance of Glycosylated hemoglobin (HbA1c) in diabetes mellitus patients”. Retrievedfrom https://www.researchgate.net/publication/26575867_Clinical_Importance_Of_Glycosylated_Hemoglobin_HbA1c_In_Diabetes_Mellitus_Patients. [Last accessed on march 11th 2018].
Dua S, Bhuker M, Sharma P, Dhall M, Kapoor S. Body mass index relates to blood pressure among adults. North Am J Med Sci 2014; 6:89-95.
Danasekaran R, Vinoth R. A study on relation between BMI and hypertension among adolescents in Kancheepuram district, Tamil Nadu. IJAR. 2015; 1 (2): 8-12.
Chaudhury A, Duvoor C, Reddy V, et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front. Endocrinol. 2017; 8 (6):1-12.
Perwitasari D, Urbayatun S. Treatment Adherence and Quality of Life in Diabetes Mellitus Patients in Indonesia. Sage Open. 2016:1-7.